Medgenics Inc Share Price (MEDG)
| Bid price | 330.00 | Open price | 342.50 |
|---|---|---|---|
| Ask price | 355.00 | Prev close | 342.50 |
| High price | 0.00 | Spread | 7.04% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Medgenics Inc share prices, Medgenics Inc stock quotes, charts, trades and FREE Medgenics Inc company fundamentals, market news and much much more. Why not upgrade to a premium service and get Medgenics Inc Level 2 Data, indepth research tools and investor commentary for Medgenics Inc (MEDG) and other London Stock Exchange equities.
Medgenics Inc Share Price Chart
Register now for FREE Medgenics Inc share price charts
Medgenics Inc Share Price Information
| Name | Medgenics Inc | Epic | MEDG |
|---|---|---|---|
| Activites | Researches and develops therapeutic protein delivery technology for the treatment of a range of chronic diseases | Reuters | MEDG.L |
| ISIN | USU582411158 | Google Finance | LON:MEDG |
| Share Price (p) | 342.50 | Prev. Share Price (p) | 342.50 |
|---|---|---|---|
| Shares in Issue (m) | 10 | Market Cap (£m) | 33 |
| PE Ratio (x) | Div per share (p) | 0.00 | |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -96.00 | PEG |
Register now for FREE Medgenics Inc company fundamentals
Medgenics Inc Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 30/12/2010 | EXR | Eugene Bauer | CH | 1,990,081 |
| 24/12/2010 | LOF | Eugene Bauer | CH | 2,000,000 |
| 07/06/2010 | EXR | Andrew Pearlman | CEO | 3,166 |
Medgenics Inc Company News
Medgenics to Present at 11th Annual ILSI BIOMED
/* */ RNS Number : 6487D Medgenics Inc 18 May 2012 Press Release 18 May 2012 Medgenics To Present at the 11th Annual ILSI BIOMED 2012 Medgenics,...
Medgenics gets FDA go-ahead for Epodure trial
Medgenics has been given clearance by the US Food and Drug Administration to start phase IIb trial of Epodure for sustained anaemia treatment in dialysis patients. Medgenics says this multi-centre, randomised clinical trial will be the first study in the US using the the company's proprietary...
FDA Clearance for Phase IIb Trial of EPODURE
/* */ RNS Number : 5697D Medgenics Inc 17 May 2012 Press Release 17 May 2012 Medgenics Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for...
More Medgenics Inc Company News >>
Register now for FREE Medgenics Inc company news
Medgenics Inc Share Price Discussions
No Medgenics Inc Share Price Discussions
Register now for FREE Medgenics Inc share price discussions